← Open Payments lookup

TAMMY WOLVERTON: Open Payments

NPI 1770139586 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$653 in 30 payments from 10 companies in 2025. Trend: 2023 $299 · 2024 $225 · 2025 $653

Food & beverage: $653
CompanyPaymentsAmount
Alkermes, Inc.15$346
Teva Pharmaceuticals USA, Inc.5$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Otsuka America Pharmaceutical, Inc.2$32
Vanda Pharmaceuticals Inc.1$32
Neos Therapeutics, LP1$22
Luye Pharma (USA) Ltd.1$21
Neurocrine BioSciences, Inc.1$21
Supernus Pharmaceuticals, Inc.1$18
Corium, LLC1$17

Products named: LYBALVI, ARISTADA, UZEDY, AUSTEDO XR, CAPLYTA, FANAPT, Adzenys XR-ODT, ERZOFRI EXTENDED-RELEASE.

Industry payments across IN — which companies pay providers there.